OYST
Oyster Point Pharma, Inc.
No insider bought or sold Oyster Point Pharma, Inc. in the last 12 months
OYST over the last year
Prices for OYST aren't in yet.
OYST after insider buys
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
15 insider filings since 2019, newest first
Versant Venture Capital Vi, L.P. · 10% owner
William J Phd Link · Director
Clare Ozawa · Director and 10% owner
John Snisarenko · Chief Commercial Officer
Invopps Gp Iv, L.L.C. · Director and 10% owner
Invopps Gp Iv, L.L.C. · Director and 10% owner
John Snisarenko · Chief Commercial Officer
Daniel Lochner · CFO
Kkr Fund Holdings L.P. · 10% owner
Vida Ventures, LLC · 10% owner
Falcon Vision LLC · 10% owner
New Enterprise Associates 14, L.P. · 10% owner
Versant Venture Capital Vi, L.P. · 10% owner
Clare Ozawa · Director
William J Phd Link · Director and 10% owner
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.